Omvoh® (mirikizumab-mrkz)
for Ulcerative Colitis

Omvoh (mirikizumab) is a biologic treatment for adults with inflammatory bowel disease (IBD), including ulcerative colitis and Crohn’s disease. Administered via IV infusion or subcutaneous injection, it manages moderate to severe cases by blocking interleukin-23 (IL-23), a key driver of inflammation. By inhibiting IL-23, Omvoh helps reduce symptoms and control inflammation in the gut.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Ulcerative Colitis - UC